Dr. Reddy's Laboratories Ltd
RDY Healthcare Drug Manufacturers Specialty & Generic
Dr. Reddy's Laboratories Ltd’s revenue for fiscal 2026 (year ended March 2026) was $3.6 billion, down 6.06% from fiscal 2025. In the quarter to June 2026, revenue fell 14.4%, EPS fell 70.0%, free cash flow fell 143.4% and total debt rose 34.0%, each against the same quarter a year earlier.
Follow RDY
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
865.00 | 938.00 | 923.00 | 788.00 |
+8 more quarters Free account |
Receivables |
1,062.00 | 1,079.00 | 1,149.00 | 1,101.00 | |
Inventory |
850.00 | 816.00 | 879.00 | 854.00 | |
Other current assets |
384.00 | 386.00 | 361.00 | 406.00 | |
Total current assets |
3,162.00 | 3,219.00 | 3,312.00 | 3,148.00 | |
Property, Plant, Equpment (Net) |
1,221.00 | 1,236.00 | 1,286.00 | 1,261.00 | |
Long-Term Investments |
167.00 | 174.00 | 111.00 | 110.00 | |
Goodwill and Intangible Assets (Total) |
1,230.00 | 1,257.00 | 1,277.00 | 1,276.00 | |
Long Term Assets (Tax, Deferred) |
245.00 | 239.00 | 237.00 | 256.00 | |
Long-term assets (Other) |
52.00 | 50.00 | 43.00 | 54.00 | |
Total non-current assets |
2,915.00 | 2,956.00 | 2,954.00 | 2,957.00 | |
Total Assets |
6,077.00 | 6,175.00 | 6,266.00 | 6,105.00 | |
Accounts Payable |
396.00 | 356.00 | 454.00 | 453.00 | |
Current Part of Debt |
634.00 | 694.00 | 625.00 | 529.00 | |
Current Part of Taxes to Pay |
45.00 | 46.00 | 62.00 | 86.00 | |
Other current liabilities |
586.00 | 691.00 | 621.00 | 633.00 | |
Total current liabilities |
1,661.00 | 1,787.00 | 1,762.00 | 1,700.00 | |
Long Term Debt (Total) |
126.00 | 130.00 | 129.00 | 131.00 | |
Long Term Tax Liability (Deferred) |
171.00 | 166.00 | 165.00 | 167.00 | |
Non-current Liabilities (Other) |
33.00 | 38.00 | 27.00 | 29.00 | |
Total non-current liabilities |
330.00 | 334.00 | 321.00 | 327.00 | |
Total liabilities |
1,991.00 | 2,121.00 | 2,083.00 | 2,027.00 | |
Additional Paid In Capital |
121.00 | 121.00 | 126.00 | 127.00 | |
Common Stock (Net) |
9.00 | 9.00 | 9.00 | 9.00 | |
Retained Earnings |
3,765.00 | 3,751.00 | 3,894.00 | 3,804.00 | |
Treasury Stock |
17.00 | 19.00 | 21.00 | 22.00 | |
Shareholders Equity (Other) |
172.00 | 156.00 | 137.00 | 119.00 | |
Common Equity (Total) |
4,085.00 | 4,054.00 | 4,183.00 | 4,077.00 | |
Shareholders Equity (Total) |
4,086.00 | 4,054.00 | 4,183.00 | 4,078.00 | |
Shareholders Equity and Liabilities (Total) |
6,077.00 | 6,175.00 | 6,266.00 | 6,105.00 | |
Shares (Common) |
834.68 | 834.66 | 834.63 | 834.61 | |
Shareholders Equity (Tangible) |
2,856.00 | 2,797.00 | 2,906.00 | 2,802.00 | |
Net Debt |
(105.00) | (114.00) | (169.00) | (128.00) | |
Total Debt |
760.00 | 824.00 | 754.00 | 660.00 |